| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.08 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.14 | 0.08 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.057 | 0.09 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.089 | 0.09 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.09 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.067 | 0.09 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.092 | 0.09 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.091 | 0.09 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.09 |